BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Agarwal VK, McHutchison JG, Hoofnagle JH; Drug-Induced Liver Injury Network. Important elements for the diagnosis of drug-induced liver injury. Clin Gastroenterol Hepatol. 2010;8:463-470. [PMID: 20170750 DOI: 10.1016/j.cgh.2010.02.008] [Cited by in Crossref: 102] [Cited by in F6Publishing: 86] [Article Influence: 9.3] [Reference Citation Analysis]
Number Citing Articles
1 Raschi E, Poluzzi E, Koci A, Caraceni P, Ponti FD. Assessing liver injury associated with antimycotics: Concise literature review and clues from data mining of the FAERS database. World J Hepatol 2014; 6(8): 601-612 [PMID: 25232453 DOI: 10.4254/wjh.v6.i8.601] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 6.6] [Reference Citation Analysis]
2 Avigan MI, Bjornsson ES, Pasanen M, Cooper C, Andrade RJ, Watkins PB, Lewis JH, Merz M. Liver safety assessment: required data elements and best practices for data collection and standardization in clinical trials. Drug Saf 2014;37 Suppl 1:S19-31. [PMID: 25352325 DOI: 10.1007/s40264-014-0183-6] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
3 Whritenour J, Ko M, Zong Q, Wang J, Tartaro K, Schneider P, Olson E, Van Volkenburg M, Serrano J, Hayashi P, Fontana R, Chalasani N, Bonkovsky HL. Development of a modified lymphocyte transformation test for diagnosing drug-induced liver injury associated with an adaptive immune response. J Immunotoxicol 2017;14:31-8. [PMID: 28121193 DOI: 10.1080/1547691X.2016.1254305] [Cited by in Crossref: 17] [Cited by in F6Publishing: 4] [Article Influence: 4.3] [Reference Citation Analysis]
4 Abid A, Subhani F, Kayani F, Awan S, Abid S. Drug induced liver injury is associated with high mortality-A study from a tertiary care hospital in Pakistan. PLoS One 2020;15:e0231398. [PMID: 32276267 DOI: 10.1371/journal.pone.0231398] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
5 Avigan MI, Mozersky RP, Seeff LB. Scientific and Regulatory Perspectives in Herbal and Dietary Supplement Associated Hepatotoxicity in the United States. Int J Mol Sci. 2016;17:331. [PMID: 26950122 DOI: 10.3390/ijms17030331] [Cited by in Crossref: 54] [Cited by in F6Publishing: 43] [Article Influence: 10.8] [Reference Citation Analysis]
6 Chalasani NP, Maddur H, Russo MW, Wong RJ, Reddy KR; Practice Parameters Committee of the American College of Gastroenterology. ACG Clinical Guideline: Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury. Am J Gastroenterol 2021;116:878-98. [PMID: 33929376 DOI: 10.14309/ajg.0000000000001259] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 Teschke R, Frenzel C, Glass X, Schulze J, Eickhoff A. Greater Celandine hepatotoxicity: a clinical review. Annals of Hepatology 2012;11:838-48. [DOI: 10.1016/s1665-2681(19)31408-5] [Cited by in Crossref: 30] [Article Influence: 3.3] [Reference Citation Analysis]
8 Ocete Hita E, Martín García J, Giménez Sánchez F, Flores González J, Abril Molina A, Salmerón Escobar J, Ruiz Extremera A. Hepatotoxicidad por fármacos o productos naturales en niños. Anales de Pediatría 2013;78:248-59. [DOI: 10.1016/j.anpedi.2012.06.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
9 Philips CA, Paramaguru R, Augustine P. Reply to Ayurveda formulations induced liver injury-A myth by Dr. Preethi Mohan. Indian J Gastroenterol 2018;37:372-3. [PMID: 30121889 DOI: 10.1007/s12664-018-0873-6] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 Real M, Barnhill MS, Higley C, Rosenberg J, Lewis JH. Drug-Induced Liver Injury: Highlights of the Recent Literature. Drug Saf 2019;42:365-87. [PMID: 30343418 DOI: 10.1007/s40264-018-0743-2] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 36.0] [Reference Citation Analysis]
11 Teschke R, Danan G. Causality Assessment Methods in Drug-Induced Liver Injury. In: Chen M, Will Y, editors. Drug-Induced Liver Toxicity. New York: Springer; 2018. pp. 555-94. [DOI: 10.1007/978-1-4939-7677-5_27] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 3.7] [Reference Citation Analysis]
12 Benesic A, Leitl A, Gerbes AL. Monocyte-derived hepatocyte-like cells for causality assessment of idiosyncratic drug-induced liver injury. Gut 2016;65:1555-63. [PMID: 26045135 DOI: 10.1136/gutjnl-2015-309528] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
13 Stine JG, Lewis JH. Current and future directions in the treatment and prevention of drug-induced liver injury: a systematic review. Expert Rev Gastroenterol Hepatol. 2016;10:517-536. [PMID: 26633044 DOI: 10.1586/17474124.2016.1127756] [Cited by in Crossref: 44] [Cited by in F6Publishing: 35] [Article Influence: 7.3] [Reference Citation Analysis]
14 Hey-Hadavi J, Seekins D, Palmer M, Coffey D, Caminis J, Abdullaev S, Patwardhan M, Tyler H, Raheja R, Stanley AM, Pineda-Salgado L, Bourdet DL, Andrade RJ, Hayashi PH, Dimick-Santos L, Rockey DC, Estilo A. Overview of Causality Assessment for Drug-Induced Liver Injury (DILI) in Clinical Trials. Drug Saf 2021;44:619-34. [PMID: 33725335 DOI: 10.1007/s40264-021-01051-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Chughlay MF, Kramer N, Spearman CW, Werfalli M, Cohen K. N-acetylcysteine for non-paracetamol drug-induced liver injury: a systematic review. Br J Clin Pharmacol. 2016;81:1021-1029. [PMID: 26757427 DOI: 10.1111/bcp.12880] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
16 Avigan MI. Regulatory Perspectives. Drug-Induced Liver Disease. Elsevier; 2013. pp. 689-712. [DOI: 10.1016/b978-0-12-387817-5.00038-8] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
17 Teschke R, Wolff A, Frenzel C, Schwarzenboeck A, Schulze J, Eickhoff A. Drug and herb induced liver injury: Council for International Organizations of Medical Sciences scale for causality assessment. World J Hepatol 2014; 6(1): 17-32 [PMID: 24653791 DOI: 10.4254/wjh.v6.i1.17] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 6.9] [Reference Citation Analysis]
18 Stine JG, Northup PG. Autoimmune-like drug-induced liver injury: a review and update for the clinician. Expert Opinion on Drug Metabolism & Toxicology 2016;12:1291-301. [DOI: 10.1080/17425255.2016.1211110] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
19 Hayashi PH. Drug-Induced Liver Injury Network Causality Assessment: Criteria and Experience in the United States. Int J Mol Sci. 2016;17:201. [PMID: 26861284 DOI: 10.3390/ijms17020201] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 8.4] [Reference Citation Analysis]
20 Teschke R, Schwarzenboeck A, Schmidt-taenzer W, Wolff A, Hennermann K. Herb induced liver injury presumably caused by black cohosh: A survey of initially purported cases and herbal quality specifications. Annals of Hepatology 2011;10:249-59. [DOI: 10.1016/s1665-2681(19)31536-4] [Cited by in Crossref: 44] [Article Influence: 4.4] [Reference Citation Analysis]
21 Aithal GP, Watkins PB, Andrade RJ, Larrey D, Molokhia M, Takikawa H, Hunt CM, Wilke RA, Avigan M, Kaplowitz N, Bjornsson E, Daly AK. Case definition and phenotype standardization in drug-induced liver injury. Clin Pharmacol Ther. 2011;89:806-815. [PMID: 21544079 DOI: 10.1038/clpt.2011.58] [Cited by in Crossref: 495] [Cited by in F6Publishing: 441] [Article Influence: 49.5] [Reference Citation Analysis]
22 Chalasani NP, Hayashi PH, Bonkovsky HL, Navarro VJ, Lee WM, Fontana RJ. ACG Clinical Guideline: The Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury. American Journal of Gastroenterology 2014;109:950-66. [DOI: 10.1038/ajg.2014.131] [Cited by in Crossref: 408] [Cited by in F6Publishing: 339] [Article Influence: 58.3] [Reference Citation Analysis]
23 Kao CC, Wu PC, Wu CH, Chen LK, Chen HH, Wu MS, Wu VC. Risk of liver injury after α-glucosidase inhibitor therapy in advanced chronic kidney disease patients. Sci Rep 2016;6:18996. [PMID: 26751038 DOI: 10.1038/srep18996] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
24 Teschke R, Glass X, Schulze J, Eickhoff A. Suspected Greater Celandine hepatotoxicity: liver-specific causality evaluation of published case reports from Europe. Eur J Gastroenterol Hepatol. 2012;24:270-280. [PMID: 22189691 DOI: 10.1097/meg.0b013e32834f993f] [Cited by in Crossref: 31] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
25 Teschke R, Eickhoff A, Schulze J. Drug and herb induced liver injury in clinical and translational hepatology: Causality assessment methods, quo vadis? J Clin Translat Hepatol. 2013;1:59-74. [PMID: 26357608 DOI: 10.14218/jcth.2013.d002x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
26 Kwon H, Lee SH, Kim SE, Lee JH, Jee YK, Kang HR, Park BJ, Park JW, Hong CS. Spontaneously reported hepatic adverse drug events in Korea: multicenter study. J Korean Med Sci 2012;27:268-73. [PMID: 22379337 DOI: 10.3346/jkms.2012.27.3.268] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
27 Jeong TB, Kim JH, Kim SH, Lee S, Son SW, Lim Y, Cho JY, Hwang DY, Kim KS, Kwak JH, Jung YS. Comparison of toxic responses to acetaminophen challenge in ICR mice originating from different sources. Lab Anim Res 2019;35:16. [PMID: 32257904 DOI: 10.1186/s42826-019-0017-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
28 Fontana RJ. Pathogenesis of idiosyncratic drug-induced liver injury and clinical perspectives. Gastroenterology. 2014;146:914-928. [PMID: 24389305 DOI: 10.1053/j.gastro.2013.12.032] [Cited by in Crossref: 147] [Cited by in F6Publishing: 130] [Article Influence: 18.4] [Reference Citation Analysis]
29 Tischer S, Fontana RJ. Drug-drug interactions with oral anti-HCV agents and idiosyncratic hepatotoxicity in the liver transplant setting. J Hepatol 2014;60:872-84. [PMID: 24280292 DOI: 10.1016/j.jhep.2013.11.013] [Cited by in Crossref: 51] [Cited by in F6Publishing: 43] [Article Influence: 6.4] [Reference Citation Analysis]
30 Hunt CM. Mitochondrial and immunoallergic injury increase risk of positive drug rechallenge after drug-induced liver injury: A systematic review. Hepatology 2010;52:2216-22. [DOI: 10.1002/hep.24022] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
31 Hayashi PH, Barnhart HX, Fontana RJ, Chalasani N, Davern TJ, Talwalkar JA, Reddy KR, Stolz AA, Hoofnagle JH, Rockey DC. Reliability of causality assessment for drug, herbal and dietary supplement hepatotoxicity in the Drug-Induced Liver Injury Network (DILIN). Liver Int 2015;35:1623-32. [PMID: 24661785 DOI: 10.1111/liv.12540] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 4.4] [Reference Citation Analysis]
32 Teschke R, Frenzel C, Schulze J, Schwarzenboeck A, Eickhoff A. Herbalife hepatotoxicity: Evaluation of cases with positive reexposure tests. World J Hepatol. 2013;5:353-363. [PMID: 23898368 DOI: 10.4254/wjh.v5.i7.535] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 Shumar J, Ordway S, Junga Z, Sadowski B, Torres D. Memantine-Induced Liver Injury With Probable Causality as Assessed Using the Roussel Uclaf Causality Assessment Method (RUCAM). ACG Case Rep J 2019;6:e00184. [PMID: 31737715 DOI: 10.14309/crj.0000000000000184] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
34 Teschke R, Danan G. Drug induced liver injury with analysis of alternative causes as confounding variables. Br J Clin Pharmacol 2018;84:1467-77. [PMID: 29607530 DOI: 10.1111/bcp.13593] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 10.0] [Reference Citation Analysis]
35 Gupta V, Trivedi P. In vitro and in vivo characterization of pharmaceutical topical nanocarriers containing anticancer drugs for skin cancer treatment. Lipid Nanocarriers for Drug Targeting. Elsevier; 2018. pp. 563-627. [DOI: 10.1016/b978-0-12-813687-4.00015-3] [Cited by in Crossref: 4] [Article Influence: 1.3] [Reference Citation Analysis]
36 Heard K, Bui A, Mlynarchek SL, Green JL, Bond GR, Clark RF, Kozer E, Koff RS, Dart RC. Toxicity from repeated doses of acetaminophen in children: assessment of causality and dose in reported cases. Am J Ther 2014;21:174-83. [PMID: 22407198 DOI: 10.1097/MJT.0b013e3182459c53] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
37 Sembera S, Lammert C, Talwalkar JA, Sanderson SO, Poterucha JJ, Hay JE, Wiesner RH, Gores GJ, Rosen CB, Heimbach JK, Charlton MR. Frequency, clinical presentation, and outcomes of drug-induced liver injury after liver transplantation. Liver Transpl 2012;18:803-10. [PMID: 22389256 DOI: 10.1002/lt.23424] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
38 Philips CA, Paramaguru R, Joy AK, Antony KL, Augustine P. Clinical outcomes, histopathological patterns, and chemical analysis of Ayurveda and herbal medicine associated with severe liver injury-A single-center experience from southern India. Indian J Gastroenterol. 2018;37:9-17. [PMID: 29476406 DOI: 10.1007/s12664-017-0815-8] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 8.7] [Reference Citation Analysis]
39 Garcia-Cortes M, Robles-Diaz M, Stephens C, Ortega-Alonso A, Lucena MI, Andrade RJ. Drug induced liver injury: an update.Arch Toxicol. 2020;94:3381-3407. [PMID: 32852569 DOI: 10.1007/s00204-020-02885-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 17.0] [Reference Citation Analysis]
40 Slim M, Medina-Caliz I, Gonzalez-Jimenez A, Cabello MR, Mayoral-Cleries F, Lucena MI, Andrade RJ. Hepatic Safety of Atypical Antipsychotics: Current Evidence and Future Directions. Drug Saf 2016;39:925-43. [PMID: 27449495 DOI: 10.1007/s40264-016-0436-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
41 Lewis JH. Drug-Induced Liver Injury Throughout the Drug Development Life Cycle: Where We Have Been, Where We are Now, and Where We are Headed. Perspectives of a Clinical Hepatologist. Pharm Med 2013;27:165-91. [DOI: 10.1007/s40290-013-0015-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 1.9] [Reference Citation Analysis]
42 Barbosa JS, Almeida Paz FA, Braga SS. Montelukast medicines of today and tomorrow: from molecular pharmaceutics to technological formulations. Drug Deliv 2016;23:3257-65. [PMID: 27011101 DOI: 10.3109/10717544.2016.1170247] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
43 Teschke R, Frenzel C, Schulze J, Eickhoff A. Spontaneous reports of primarily suspected herbal hepatotoxicity by Pelargonium sidoides: was causality adequately ascertained? Regul Toxicol Pharmacol. 2012;63:1-9. [PMID: 22381150 DOI: 10.1016/j.yrtph.2012.02.009] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 3.3] [Reference Citation Analysis]
44 Hoppmann NA, Gray ME, McGuire BM. Drug-Induced Liver Injury in the Setting of Chronic Liver Disease. Clin Liver Dis 2020;24:89-106. [PMID: 31753253 DOI: 10.1016/j.cld.2019.09.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
45 Baekdal M, Ytting H, Skalshøi Kjær M. Drug-induced liver injury: a cohort study on patients referred to the Danish transplant center over a five year period. Scand J Gastroenterol 2017;52:450-4. [PMID: 27973926 DOI: 10.1080/00365521.2016.1267790] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
46 Danan G, Teschke R. RUCAM in Drug and Herb Induced Liver Injury: The Update. Int J Mol Sci. 2015;17:14. [PMID: 26712744 DOI: 10.3390/ijms17010014] [Cited by in Crossref: 256] [Cited by in F6Publishing: 223] [Article Influence: 42.7] [Reference Citation Analysis]
47 Fontana RJ, Hayashi PH, Gu J, Reddy KR, Barnhart H, Watkins PB, Serrano J, Lee WM, Chalasani N, Stolz A, Davern T, Talwakar JA; DILIN Network. Idiosyncratic drug-induced liver injury is associated with substantial morbidity and mortality within 6 months from onset. Gastroenterology 2014;147:96-108.e4. [PMID: 24681128 DOI: 10.1053/j.gastro.2014.03.045] [Cited by in Crossref: 128] [Cited by in F6Publishing: 109] [Article Influence: 18.3] [Reference Citation Analysis]
48 Orman ES, Conjeevaram HS, Vuppalanchi R, Freston JW, Rochon J, Kleiner DE, Hayashi PH. Clinical and histopathologic features of fluoroquinolone-induced liver injury. Clin Gastroenterol Hepatol. 2011;9:517-523.e3. [PMID: 21356330 DOI: 10.1016/j.cgh.2011.02.019] [Cited by in Crossref: 75] [Cited by in F6Publishing: 66] [Article Influence: 7.5] [Reference Citation Analysis]
49 Raschi E, De Ponti F. Drug-induced liver injury: Towards early prediction and risk stratification. World J Hepatol 2017; 9(1): 30-37 [PMID: 28105256 DOI: 10.4254/wjh.v9.i1.30] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
50 Stine JG, Lewis JH. Drug-induced liver injury: a summary of recent advances. Expert Opin Drug Metab Toxicol. 2011;7:875-890. [PMID: 21510822 DOI: 10.1517/17425255.2011.577415] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 4.5] [Reference Citation Analysis]
51 Teschke R, Schulze J. Suspected herbal hepatotoxicity: requirements for appropriate causality assessment by the US Pharmacopeia. Drug Saf. 2012;35:1091-1097. [PMID: 22897137 DOI: 10.2165/11631960-000000000-00000] [Cited by in Crossref: 2] [Cited by in F6Publishing: 12] [Article Influence: 0.3] [Reference Citation Analysis]
52 Teschke R, Frenzel C, Schulze J, Schwarzenboeck A, Eickhoff A. Herbalife hepatotoxicity: Evaluation of cases with positive reexposure tests. World J Hepatol 2013; 5(7): 353-363 [PMID: 23898368 DOI: 10.4254/wjh.v5.i7.353] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
53 Ju HY, Jang JY, Jeong SW, Woo SA, Kong MG, Jang HY, Lee SH, Kim SG, Cha SW, Kim YS. The clinical features of drug-induced liver injury observed through liver biopsy: focus on relevancy to autoimmune hepatitis. Clin Mol Hepatol. 2012;18:213-218. [PMID: 22893872 DOI: 10.3350/cmh.2012.18.2.213] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
54 Oketch-Rabah HA, Roe AL, Rider CV, Bonkovsky HL, Giancaspro GI, Navarro V, Paine MF, Betz JM, Marles RJ, Casper S, Gurley B, Jordan SA, He K, Kapoor MP, Rao TP, Sherker AH, Fontana RJ, Rossi S, Vuppalanchi R, Seeff LB, Stolz A, Ahmad J, Koh C, Serrano J, Low Dog T, Ko R. United States Pharmacopeia (USP) comprehensive review of the hepatotoxicity of green tea extracts. Toxicol Rep 2020;7:386-402. [PMID: 32140423 DOI: 10.1016/j.toxrep.2020.02.008] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 33.0] [Reference Citation Analysis]
55 Raschi E, Poluzzi E, Koci A, Caraceni P, De Ponti F. Assessing liver injury associated with antimycotics: Concise literature review and clues from data mining of the FAERS database. World J Hepatol. 2014;6:601-612. [PMID: 25232453 DOI: 10.4254/wjh.v6.i8.60] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
56 Scalfaro E, Streefkerk HJ, Merz M, Meier C, Lewis D. Preliminary Results of a Novel Algorithmic Method Aiming to Support Initial Causality Assessment of Routine Pharmacovigilance Case Reports for Medication-Induced Liver Injury: The PV-RUCAM. Drug Saf 2017;40:715-27. [PMID: 28508325 DOI: 10.1007/s40264-017-0541-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
57 Teschke R, Eickhoff A, Wolff A, Frenzel C, Schulze J. Herbal hepatotoxicity and WHO global introspection method. Annals of Hepatology 2013;12:11-21. [DOI: 10.1016/s1665-2681(19)31380-8] [Cited by in Crossref: 16] [Article Influence: 2.0] [Reference Citation Analysis]
58 Tujios S, Fontana RJ. Mechanisms of drug-induced liver injury: from bedside to bench. Nat Rev Gastroenterol Hepatol. 2011;8:202-211. [PMID: 21386809 DOI: 10.1038/nrgastro.2011.22] [Cited by in Crossref: 166] [Cited by in F6Publishing: 148] [Article Influence: 16.6] [Reference Citation Analysis]
59 Björnsson ES. Hepatotoxicity by Drugs: The Most Common Implicated Agents. Int J Mol Sci. 2016;17:224. [PMID: 26861310 DOI: 10.3390/ijms17020224] [Cited by in Crossref: 101] [Cited by in F6Publishing: 84] [Article Influence: 20.2] [Reference Citation Analysis]
60 Chang C, Chang Y, Lee Y, Liu Y, Chuang L, Lin J. Severe hepatic injury associated with different statins in patients with chronic liver disease: A nationwide population-based cohort study: Hepatic injury associated with statins. J Gastroenterol Hepatol 2015;30:155-62. [DOI: 10.1111/jgh.12657] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
61 Teschke R, Frenzel C, Glass X, Schulze J, Eickhoff A. Herbal hepatotoxicity: a critical review. Br J Clin Pharmacol. 2013;75:630-636. [PMID: 22831551 DOI: 10.1111/j.1365-2125.2012.04395.x] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 5.8] [Reference Citation Analysis]
62 Lucena MI, Cohen H, Hernández N, Bessone F, Dacoll C, Stephens C, Borraz Y, Ulzurrun E, Bruguera M, Andrade RJ. Hepatotoxicidad, un problema global con especificidades locales: hacia la creación de una Red Hispano Latinoamericana de Hepatotoxicidad. Gastroenterología y Hepatología 2011;34:361-8. [DOI: 10.1016/j.gastrohep.2011.01.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
63 Soares E Silva AK, de Oliveira Cipriano Torres D, Santos Rocha SW, dos Santos Gomes FO, dos Santos Silva B, Donato MA, Raposo C, Santos AC, de Lima Mdo C, Galdino SL, da Rocha Pitta I, de Souza JR, Peixoto CA. Effect of new thiazolidine derivatives LPSF/GQ-02 and LPSF/GQ-16 on atherosclerotic lesions in LDL receptor-deficient mice (LDLR(-/-)). Cardiovasc Pathol 2013;22:81-90. [PMID: 22795892 DOI: 10.1016/j.carpath.2012.05.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
64 Fontana RJ, Avigan MI, Janssen HLA, Regev A, Mishra P, Gaggar A, Brown N, Wat C, Mendez P, Anderson RT, Given B, Miller V, Beumont M. Liver safety assessment in clinical trials of new agents for chronic hepatitis B. J Viral Hepat 2020;27:96-109. [PMID: 31828894 DOI: 10.1111/jvh.13223] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
65 Chughlay MF, Kramer N, Werfalli M, Spearman W, Engel ME, Cohen K. N-acetylcysteine for non-paracetamol drug-induced liver injury: a systematic review protocol. Syst Rev 2015;4:84. [PMID: 26066646 DOI: 10.1186/s13643-015-0075-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
66 Danan G, Teschke R. Drug-Induced Liver Injury: Why is the Roussel Uclaf Causality Assessment Method (RUCAM) Still Used 25 Years After Its Launch? Drug Saf. 2018;41:735-743. [PMID: 29502198 DOI: 10.1007/s40264-018-0654-2] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 14.7] [Reference Citation Analysis]
67 Germani G, Battistella S, Ulinici D, Zanetto A, Shalaby S, Pellone M, Gambato M, Senzolo M, Russo FP, Burra P. Drug induced liver injury: from pathogenesis to liver transplantation. Minerva Gastroenterol 2021;67. [DOI: 10.23736/s2724-5985.20.02795-6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
68 Dalal KK, Holdbrook T, Peikin SR. Ayurvedic drug induced liver injury. World J Hepatol 2017; 9(31): 1205-1209 [PMID: 29152040 DOI: 10.4254/wjh.v9.i31.1205] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
69 Heurgué-Berlot A, Bernard-Chabert B, Diebold MD, Thiéfin G. Drug-induced autoimmune-like hepatitis: a case of chronic course after drug withdrawal. Dig Dis Sci. 2011;56:2504-2505; author reply 2505. [PMID: 21698369 DOI: 10.1007/s10620-011-1786-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
70 Barge S, Ziol M, Nault J. Autoimmune-like chronic hepatitis induced by olmesartan: Barge, Ziol, and Nault. Hepatology 2017;66:2086-8. [DOI: 10.1002/hep.29228] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
71 Ma X, Peng JH, Hu YY. Chinese herbal medicine-induced liver injury. J Clin Translat Hepatol. 2014;2:170-175. [PMID: 26355537 DOI: 10.14218/jcth.2014.00009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
72 Czaja AJ. Drug-induced autoimmune-like hepatitis. Dig Dis Sci. 2011;56:958-976. [PMID: 21327704 DOI: 10.1007/s10620-011-1611-4] [Cited by in Crossref: 152] [Cited by in F6Publishing: 117] [Article Influence: 15.2] [Reference Citation Analysis]
73 Hernández N, Bessone F, Sánchez A, Pace MD, Brahm J, Zapata R, Chirino RA, Dávalos M, Méndez-sánchez N, Arrese M, Schinoni M, Lucena MI, Andrade RJ. Profile of idiosyncratic drug induced liver injury in Latin America. An analysis of published reports. Annals of Hepatology 2014;13:231-9. [DOI: 10.1016/s1665-2681(19)30886-5] [Cited by in Crossref: 22] [Article Influence: 3.1] [Reference Citation Analysis]
74 Al-nawas B, Block M, Ertl G, Franzen D, Gohlke-bärwolf C, Herrmann M, Horstkotte D, Kern W, Kramer H, Moritz A, Naber C, Peters G, Plicht B, Wahl G, Werdan K. Kommentierte Zusammenfassung der Leitlinien der European Society of Cardiology zur Infektiösen Endokarditis (Neuauflage 2009). Kardiologe 2010;4:285-94. [DOI: 10.1007/s12181-010-0282-2] [Cited by in Crossref: 23] [Cited by in F6Publishing: 1] [Article Influence: 2.1] [Reference Citation Analysis]
75 Barritt AS, Lee J, Hayashi PH. Detective work in drug-induced liver injury: sometimes it is all about interviewing the right witness. Clin Gastroenterol Hepatol. 2010;8:635-637. [PMID: 20363371 DOI: 10.1016/j.cgh.2010.03.020] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
76 Teschke R, Danan G. Diagnosis and Management of Drug-Induced Liver Injury (DILI) in Patients with Pre-Existing Liver Disease. Drug Saf. 2016;39:729-744. [PMID: 27091053 DOI: 10.1007/s40264-016-0423-z] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 9.3] [Reference Citation Analysis]
77 Lewis JH. The Art and Science of Diagnosing and Managing Drug-induced Liver Injury in 2015 and Beyond. Clin Gastroenterol Hepatol. 2015;13:2173-2189.e8. [PMID: 26116527 DOI: 10.1016/j.cgh.2015.06.017] [Cited by in Crossref: 47] [Cited by in F6Publishing: 39] [Article Influence: 7.8] [Reference Citation Analysis]
78 Teschke R, Frenzel C, Wolff A, Herzog J, Glass X, Schulze J, Eickhoff A. Initially purported hepatotoxicity by Pelargonium sidoides: the dilemma of pharmacovigilance and proposals for improvement. Annals of Hepatology 2012;11:500-12. [DOI: 10.1016/s1665-2681(19)31464-4] [Cited by in Crossref: 23] [Article Influence: 2.6] [Reference Citation Analysis]
79 Teschke R, Schwarzenboeck A, Eickhoff A, Frenzel C, Wolff A, Schulze J. Clinical and causality assessment in herbal hepatotoxicity. Expert Opin Drug Saf. 2013;12:339-366. [PMID: 23458441 DOI: 10.1517/14740338.2013.774371] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 5.3] [Reference Citation Analysis]
80 Teschke R, Schmidt-Taenzer W, Wolff A. Spontaneous reports of assumed herbal hepatotoxicity by black cohosh: is the liver-unspecific Naranjo scale precise enough to ascertain causality? Pharmacoepidemiol Drug Saf. 2011;20:567-582. [PMID: 21702069 DOI: 10.1002/pds.2127] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 3.7] [Reference Citation Analysis]
81 Bunchorntavakul C, Reddy KR. Review article: herbal and dietary supplement hepatotoxicity. Aliment Pharmacol Ther. 2013;37:3-17. [PMID: 23121117 DOI: 10.1111/apt.12109] [Cited by in Crossref: 167] [Cited by in F6Publishing: 146] [Article Influence: 18.6] [Reference Citation Analysis]
82 Tujios SR, Lee WM. Acute liver failure induced by idiosyncratic reaction to drugs: Challenges in diagnosis and therapy. Liver Int. 2018;38:6-14. [PMID: 28771932 DOI: 10.1111/liv.13535] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 7.8] [Reference Citation Analysis]
83 Teschke R, Andrade RJ. Drug-induced liver injury: expanding our knowledge by enlarging population analysis with prospective and scoring causality assessment. Gastroenterology 2015;148:1271-3. [PMID: 25921378 DOI: 10.1053/j.gastro.2015.04.027] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
84 Teschke R, Frenzel C, Wolff A, Eickhoff A, Schulze J. Drug induced liver injury: accuracy of diagnosis in published reports. Annals of Hepatology 2014;13:248-55. [DOI: 10.1016/s1665-2681(19)30888-9] [Cited by in Crossref: 41] [Article Influence: 5.9] [Reference Citation Analysis]
85 Devarbhavi H, Aithal G, Treeprasertsuk S, Takikawa H, Mao Y, Shasthry SM, Hamid S, Tan SS, Philips CA, George J, Jafri W, Sarin SK; Asia Pacific Association of Study of Liver. Drug-induced liver injury: Asia Pacific Association of Study of Liver consensus guidelines. Hepatol Int 2021;15:258-82. [PMID: 33641080 DOI: 10.1007/s12072-021-10144-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
86 Teschke R, Schulze J. Suspected Herbal Hepatotoxicity: Requirements for Appropriate Causality Assessment by the US Pharmacopeia. Drug Saf 2012;35:1091-7. [DOI: 10.1007/bf03261996] [Cited by in Crossref: 28] [Article Influence: 3.1] [Reference Citation Analysis]